One in Five Physicians Likely To Purchase an iPad, More than 60 Percent Intrigued By New Device According to Epocrates Survey
Epocrates, Inc., today announced its top-ranked clinical
reference application for the iPhone® and iPod® touch devices will
be customized for the new iPad™ computer tablet. The iPad is
already receiving a warm reception from the healthcare industry
with nearly 20 percent of clinicians expressing plans to purchase
in an Epocrates survey conducted days after the Apple
“By optimizing our software for the iPad, we are capitalizing on
the larger screen real estate and interactivity provided by this
sophisticated device. We are committed to providing the most
productive experience at the point of care, keeping physicians
informed and focused on the patient rather than searching for
answers,” said Rose Crane, chief executive officer of Epocrates.
“We are continuing to explore the advanced capabilities of the iPad
and ways it can help Epocrates address the evolving healthcare
In addition to announcing its engineers are using Apple’s SDK to
optimize Epocrates’ offerings for the iPad, Epocrates surveyed more
than 350 clinicians to gauge their interest in the new tablet.
- Nine percent of survey
respondents plan to buy the iPad when it was immediately
- Another 13 percent plan to buy
it within the year,
- Thirty-eight percent of
respondents expressed interest in the iPad with the request of more
information to solidify their purchase decision.
Epocrates®, the first medical application available using the
iPhone SDK, was quickly adopted by medical professionals across the
nation. Today, as the most popular medical program in the Apple app
store, more than one in five physicians are actively using
Epocrates on their iPhone or iPod touch. The majority of Epocrates’
275,000-plus physician subscribers actively use its free or premium
software on a “smartphone” such as an iPhone, Blackberry® or Palm®
More than 900,000 clinicians worldwide rely on Epocrates
software at the point of care to help improve patient safety and
increase efficiencies with fast, reliable access to a host of
clinical information, such as drug dosing, health plan coverage and
disease treatment guidelines.
ABOUT EPOCRATES, INC.
Epocrates is a leading provider of clinical information and
decision support tools to healthcare professionals. Epocrates
currently has more than 900,000 healthcare professionals, including
one in three U.S. physicians and 40 percent of medical students, in
its active network. The company’s subscription-based services
enable healthcare professionals to make more informed medical
decisions, reduce medical errors and practice more efficiently. For
more information about Epocrates, please visit
All trademarks are properties of
their respective owners.